raynaud's phenomenon secondary to systemic sclerosis
Showing 1 - 3 of 3
Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in United States (Placebo IV infusion, Iloprost Injection, for
Completed
- Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Placebo IV infusion
- Iloprost Injection, for intravenous use
-
Phoenix, Arizona
- +29 more
Jul 13, 2021
Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in France, Germany, United Kingdom (Selexipag, Placebo)
Completed
- Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Selexipag
- Placebo
-
Grenoble cedex, France
- +15 more
May 9, 2016
Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in United States (Alprostadil, Placebo)
Completed
- Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Alprostadil
- Placebo
-
Encinitas, California
- +3 more
Mar 21, 2016